Position in GLSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$949,293
+$496,633 QoQ
Shares Held
39,521
+83.4% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. GLSI ranks #256 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in GLSI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $949,293 | 39,521 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $452,660 | 21,545 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $197,457 | 19,845 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $149,636 | 16,498 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $169,236 | 15,070 | Shares | Defined | 2025-02-11 | |
| 2024-03-31 | $827,609 | 41,505 | Shares | Defined | 2024-05-15 | |
| 2022-06-30 | $104,367 | 12,322 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||